A new study, presented at the SNM 55th Annual Meeting, shows that radioimmunotherapy (RIT) targeting viral antigens offers a novel option to treat—or even prevent—many viral cancers by targeting cancer cells expressing viral antigens or infected cells before they convert into malignancy.
Get the full story...
